| Literature DB >> 33903957 |
Marilena M DeMayo1, Izabella Pokorski1, Yun J C Song1, Rinku Thapa1, Shrujna Patel1, Zahava Ambarchi1, Domenic Soligo2, Indra Sadeli1, Emma E Thomas1, Ian B Hickie1,3, Adam J Guastella4.
Abstract
There is an increasing interest in using magnetic resonance imaging (MRI) as a tool for precision medicine in autism spectrum disorder (ASD). This study investigated the feasibility of MRI scanning in a large comprehensive, inclusive and test heavy clinical trial for children (aged 3-12 years) with ASD, without functioning constraints for participation. Of the 71 participants enrolled who consented to the MRI, 24 participants (38%) successfully completed an MRI scan at baseline along with other assessments. This scanning followed a familiarization procedure at two preceding visits. At post-treatment, 21 participants successfully completed the MRI scan. This study highlights the challenge of completing MRI assessments in ASD populations when conducted as one of a number of tests in a clinical trial.Entities:
Keywords: Autism spectrum disorders; Biomarkers; Brain function; Brain structure; Clinical trial; Interventions–pharmacologic; Magnetic resonance imaging; Neuroimaging; Pre-school children; School-age children
Mesh:
Year: 2021 PMID: 33903957 DOI: 10.1007/s10803-021-05028-2
Source DB: PubMed Journal: J Autism Dev Disord ISSN: 0162-3257